سامانه مدیریت نشریات علمی دانشگاه علوم پزشکی مشهد

Onyebuchi, Ekene, Ajike, Sunday, Yusuf, Rasheed, Fomete, Benjamin. (1401). Alkaline Phosphatase Profile of Patients with Fibro-Osseous Lesions. , 34(6), 311-318. doi: 10.22038/ijorl.2022.63776.3185
Ekene Polycarp Onyebuchi; Sunday Olusegun Ajike; Rasheed Yusuf; Benjamin Fomete. "Alkaline Phosphatase Profile of Patients with Fibro-Osseous Lesions". , 34, 6, 1401, 311-318. doi: 10.22038/ijorl.2022.63776.3185
Onyebuchi, Ekene, Ajike, Sunday, Yusuf, Rasheed, Fomete, Benjamin. (1401). 'Alkaline Phosphatase Profile of Patients with Fibro-Osseous Lesions', , 34(6), pp. 311-318. doi: 10.22038/ijorl.2022.63776.3185
Onyebuchi, Ekene, Ajike, Sunday, Yusuf, Rasheed, Fomete, Benjamin. Alkaline Phosphatase Profile of Patients with Fibro-Osseous Lesions. , 1401; 34(6): 311-318. doi: 10.22038/ijorl.2022.63776.3185

Alkaline Phosphatase Profile of Patients with Fibro-Osseous Lesions

Iranian Journal of Otorhinolaryngology
مقاله 6، دوره 34، شماره 6، بهمن و اسفند 2022، صفحه 311-318    اصل مقاله (567.55 K)
نوع مقاله: Original
شناسه دیجیتال (DOI): 10.22038/ijorl.2022.63776.3185
نویسندگان
Ekene Polycarp Onyebuchi* 1؛ Sunday Olusegun Ajike2؛ Rasheed Yusuf3؛ Benjamin Fomete2
1Maxillofacial Surgery Unit, Alex Ekwueme Federal Teaching Hospital, Abakaliki, Ebonyi State, Nigeria.
2Maxillofacial Surgery Unit, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria.
3Chemical Pathology Department, Ahmadu Bello University Teaching, Zaria, Kaduna State, Nigeria.
چکیده
Introduction:
Although some studies on craniofacial fibro-osseous lesions have assayed serum alkaline phosphatase levels of affected patients, the findings of these reports are often inconclusive. The aim of this study was to determine the association between the serum ALP levels of individuals with craniofacial fibro-osseous lesions (CFOLs) and treatment outcome.
Materials and Methods:
Consecutive patients who presented at the Ahmadu Bello University Teaching Hospital, Zaria from May, 2016 to December, 2017 with lesions histologically diagnosed as CFOLs. The Speight and Carlos’ (2006) classification of CFOLs was adopted, and the serum ALP level of patients and their age- and- gender matched apparently healthy controls were measured at presentation, and repeated at the 3rd and 6th post-operative months for subjects only. Treatment outcomes were assessed 6 months post treatment.
Results:
Fifty cases of CFOLs were recorded with a male preponderance, while fibrous dysplasia was the most prevalent lesion, and the maxilla was the most affected jaw (62%). Only 11 subjects had elevated serum ALP levels at presentation, and the mean serum ALP level of subjects with CFOLs was higher (341.2 ± 198.1 IU/L) than that of their age-and gender-matched controls (190.7 ± 110.2 IU/L). With the exception of subjects whose lesions recurred, there was a decrease in the mean serum ALP levels of subjects by the 3rd (245 ± 170.2 IU/L) and 6th (240.5 ± 172.7 IU/L) months post-treatment. Thirty three subjects had elimination of lesions, while three cases each recurred or developed morbidity.                     
Conclusion:
The treatment outcomes of patients with fibrous dysplasia appear to be associated with their serum ALP level. Therefore, serial serum ALP level monitoring suggested in the management of patients with fibrous dysplasia of the craniofacial region.
کلیدواژه‌ها
Alkaline phosphatase؛ Craniofacial؛ Fibro-osseous؛ Treatment outcomes
مراجع
  1. Waldron CA. Fibro-osseous lesions of the jaws. J Oral Maxillofac Surg 1985; 43:249-62.
  2. Eversole R, Su L, El-Mofty S. Benign fibro-osseous lesions of the craniofacial complex: a review. Head and Neck Pathol 2008; 2:177-202.
  3. Jundt G. Fibrous dysplasia. In: Barnes L, Eveson JW, Reichart P, Sidransky D, (editors). World Health Organization classification of tumours: Pathology and genetics of the head and neck tumours. Lyon: International Agency for Research on Cancer (IARC); 2005. Pp. 321-22.
  4. Brannon RB, Fowler CB. Benign fibro-osseous lesions: a review of current concepts. Adv Anat Pathol 2001; 8:126-43.
  5. Aldred MA, Trembath RC. Activating and inactivating mutations in the human GNAS1 gene. Hum Mutat 2000; 16:183-89.
  6. Pimenta FJ, Silveira LFG, Tavares GC, Silva AC, Perdigão PF, Castro WH, et al. HRPT2 gene alterations in ossifying fibroma of the jaws. Oral Oncology 2006; 42:735-39.
  7. Coleman JE. Structure and mechanism of alkaline phosphatase. Ann Rev Biophys Biomol Struct 1992; 21:441-83.
  8. Sarathchandra P, Cassella JP, Ali SY. Enzyme histochemical localization of ALP activity in osteogenesis imperfecta bone and growth plate: a preliminary study. Micron 2005; 36: 715-720.
  9. Park BY, Cheon YW, Kim YO, Pae NS, Lee WJ. Prognosis of craniofacial fibrous dysplasia after incomplete resection: age and serum alkaline phosphatase. Int J Oral Maxillofac Surg 2010; 39:221-26.
  10. Feller L, Wood NH, Khammissa RAG, Lemmer J, Raubenheimer EJ. The nature of fibrous dysplasia. Head Face Med 2009; 2:1-5.
  11. Mahadesh J, Gowda C, Devi L, Kokila G. Fibrous dysplasia of the jaw bones: clinical, radiographical and histopathological features. Report of two cases. J Dent Sci Res 2011; 2:18-25.
  12. More CB, Shirolkar R, Adalja C, Tailor MN. Florid cemento-osseous dysplasia of the maxilla and mandible: a rare clinical case. Braz J Oral Sci 2012; 11:513-17.
  13. Diwan N, Chavan M, Shete A, Khedkar S. Craniofacial fibrous dysplasia: report of a case using computerized tomographic scan diagnosis. J Orofac Sci 2013; 5:67-70.
  14. Delibasi O, Deniz E, Ekici ID. Monostotic fibrous dysplasia of the mandible. Oral Health Dent Manag 2014; 13:326-29.
  15. Cheng J, Wang Y, Yu H, Wang D, Ye J, Jiang H, et al. An epidemiological and clinical analysis of craniomaxillofacial fibrous dysplasia in a Chinese population. Orphanet J Rare Dis 2012; 7:80-85.
  16. Goncalves M, Pispico R, Alves FdA, Lugao CB, Goncalves A. Clinical, radiological, biochemical and histological findings of florid cemento-osseous dysplasias. Report of a case. Braz Dent J 2005; 16:247-50.
  17. Menon S, Venkatswamy S, Ramu V, Banu K, Ehtaih S, Kashyap VM. Craniofacial         fibrous dysplasia: surgery and literature review. Ann maxillofac Surg 2013; 3:66-71.
  18. Regezi JA. Odontogenic cysts, odontogenic tumours, fibro-osseous and giant cell lesions of the jaws. Mod Pathol 2002; 15:331-41.
  19. Wang TT, Zhang R, Wang L, Chen Y, Dong Q, Li TJ. Two cases of multiple ossifying fibromas in the jaws. Diagn Pathol 2014; 9:75-84.
  20. MacDonald-Jankowski DS. Cemento ossifying fibromas in the jaws of Hong Kong Chinese. Dentomaxillofac Radiol 1998; 27:298-304.
  21. Valentini V, Cassoni A, Marianetti TM, Terenzi V, Fadda MT, Ianetti G. Craniomaxillofacial fibrous dysplasia: conservative treatment or radical surgery? A retrospective study of 68 patients. Plast Reconstr Surg 2009; 123:653-60.
  22. Suarez-Soto A, Ruiz de la Hermosa MC, Minguez-Martinez I, Floria-Garcia LM, Barea-Gamiz J, Delhom-Valero J, et al. Management of fibro-osseous lesions of the craniofacial area. Presentation of 19 cases and review of the literature. Med Oral Patol Oral Cir Bucal 2013; 18:e479-e85.
  23. Alawi F. Benign Fibro-osseous diseases of the maxillofacial bones: a review and differential diagnosis. Am J Clin Pathol 2002; 118:s50-s70.
  24. Slootweg PJ, Panders AK, Koopmans R, Nikkels PG. Juvenile ossifying fibroma. An analysis of 33 cases with emphasis on histopathological aspects. J Oral Pathol Med 1994; 23:385-89.
  25. Neville BW, Damm DD, Allen CM, Bouquot JE. Bone pathology. In: Neville BW, Damm DD, Allen CM, Bouquot JE, editors. Oral and Maxillofacial Pathology. Missouri: Saunders- Elsevier; 2009. Pp. 613-77.
  26. Melrose RJ. The clinicopathologic spectrum of cemento-osseous dysplasias. Oral Maxillofac Surg Clin North Am 1997; 9:643-53.
  27. MacDonald-Jankowski DS. Florid cemento-osseous dysplasia: a systematic review. Dentomaxillofac Radiol 2003; 32:141-49.
 

 

آمار
تعداد مشاهده مقاله: 325
تعداد دریافت فایل اصل مقاله: 227